SerenQ Ipamorelin + CJC 1295 (No Dac) Peptide Pen
SerenQ Ipamorelin + CJC 1295 (No Dac) Peptide Pen
In short 产品简述
Ipamorelin 10mg + CJC-1295 (no DAC) 5mg, pre-blended in a SerenQ injection pen. No reconstitution, no mixing two vials, no drawing up. Dial the units, read them off the window, done.
Specifications 规格参数
About the Product 产品详情
UK Launch · The Ped Shop Exclusive
A new name in research peptides, landing in the UK
SerenQ Pharmaceuticals builds research peptides into sealed, pre-filled injection pens rather than lyophilised vials. No reconstitution, no bacteriostatic water, no guesswork with a syringe barrel. Dial the units you need, read them off the window, done. Blends arrive pre-mixed at a fixed ratio, so there is nothing to combine.
SerenQ has appointed
The Ped Shop as its exclusive UK stockist
. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.
SerenQ Pharmaceuticals
Ipamorelin + CJC-1295NO DAC
Blended Peptide Injection Pen System
Ipamorelin 10mg CJC-1295 5mg
Content10mg + 5mg
Dial graduation9u = 300 / 150mcg
Per unit33.3 / 16.7mcg
Total units300u
FormatPre-filled pen
Pen tips32G 0.23 x 4mm
Expiry12/2027
AuthenticityQR + serial
Composition & Dosing Guide
The Ipamorelin + CJC-1295 pen holds 3ml of solution across 300 units, so one unit on the dial equals 0.01ml. That works out at 3.33mg/ml Ipamorelin, 1.67mg/ml CJC-1295. As a worked example, 9 units is 0.09ml, containing 0.30mg Ipamorelin, 0.15mg CJC-1295. Figures are the pen’s stated contents divided across its 300 units. For research purposes only. Not for human consumption.
Third Party Testing
Results in
This batch has been independently analysed by
Analiza Białek
in Wrocław. A sealed pen was pulled from production stock and tested by HPLC. These are the figures that came back, and the full certificate is in the gallery above.
Ipamorelin
Content per ml
3.69mg/ml
Total in pen
11.07mg / 3ml
Label claim
Result
111% of label
CJC-1295 No DAC
Content per ml
1.56mg/ml
Total in pen
4.98mg / 3ml
Label claim
Result
100% of label
Laboratory
Analiza Białek
Method
HPLC
Tested
3 September 2026
Password
S13JU98K
Check it yourself at
using password
S13JU98K
. Order number 100017373.
Serialised & QR Verified
Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.
One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.
You can verify your SerenQ authenticity and view the latest HPLC at
About the blend
This pen holds two compounds in a fixed 2:1 ratio, and the reason they are paired is that they approach the same gland from two different doors.
Ipamorelin
is a pentapeptide growth hormone secretagogue that acts on the ghrelin receptor, GHS-R1a. What set it apart from earlier secretagogues such as GHRP-6 and GHRP-2 was selectivity: published work reported growth hormone release with comparatively little disturbance to cortisol, prolactin and ACTH, and a pulsed rather than sustained release pattern.
CJC-1295 no DAC
, also written Modified GRF (1-29), is a different animal entirely. It is a shortened 29 amino acid GHRH analogue carrying four amino acid substitutions, each one there to blunt breakdown by the DPP-4 enzyme that dismantles natural GHRH within minutes. It acts on the GHRH receptor.
What “no DAC” actually means:
DAC stands for Drug Affinity Complex, a chemical group that binds the peptide to serum albumin and stretches its half-life out to days. This pen does
carry it. Without DAC the compound clears in roughly half an hour, which is why the research literature describes it as producing a short pulse rather than a sustained elevation. If you are looking for the long acting version, this is not it.
The rationale for combining them is receptor arithmetic. One acts on the GHRH receptor, the other on the ghrelin receptor, and studies examining GHRH analogues alongside secretagogues have reported a greater combined response than either produces alone. Both are short acting here, which is the point of the pairing rather than an oversight.
Where the evidence sits:
neither compound holds a medicines licence in the UK or anywhere else. Ipamorelin reached early clinical investigation before development was abandoned. CJC-1295 no DAC has not been through clinical development at all, and research on the combination specifically is limited. It is supplied here strictly as a laboratory research chemical.
The pen format
10mg Ipamorelin + 5mg CJC-1295 no DAC
per pen, pre-blended in solution
1 unit = 33.3mcg Ipamorelin and 16.7mcg CJC-1295
9 units on the dial gives 300mcg / 150mcg
300 units in total
, which works out at 33 full 9 unit draws per pen
– Dial and dose window let you set the exact amount and read it back before dispensing
– 4 screw on pen tips supplied, individually sealed,
32G 0.23 x 4mm
– Protective cap, clip and a rigid retail carton for storage and transport
– Batch number, expiry and serial printed directly on the pen barrel, not just the box
Handling and storage
– Store refrigerated at 2 to 8°C. Do not freeze
– Keep in the outer carton, away from direct light
– Short periods at room temperature during transit are expected and normal
– Use a fresh sealed tip for each dispense and dispose of tips in a sharps container
– Expiry 12/2027 on sealed, correctly stored stock
– Keep out of reach of children and animals
What is in the box
– 1 × SerenQ Ipamorelin 10mg + CJC-1295 no DAC 5mg pre-filled injection pen
– 4 × sealed pen tips, 32G 0.23 x 4mm
– Serialised, QR coded retail carton
For research purposes only
This product is sold strictly as a laboratory research chemical.
It is not a medicine, not a supplement and not a cosmetic. It is
not for human or veterinary consumption
, and it is not intended to diagnose, treat, cure or prevent any disease or condition.
Neither Ipamorelin nor CJC-1295 is licensed as a medicinal product by the MHRA, the FDA or any other regulator. Nothing on this page should be read as medical advice, a recommendation, or a suggesti
Third-Party Testing 第三方检测
What's in the Box 包装清单
- 1 × 预充注射笔
- 配套密封笔尖（数量以供应商包装为准）
Usage 使用说明
- 每次使用更换全新密封笔尖
- 旋拧刻度并核对剂量窗口
- 按研究方案设定的剂量给药
Handling & Storage 储存条件
- 2-8°C 冷藏，勿冷冻
- 避光保存于原包装盒内
- 首次启用后按供应商建议的期限内使用
Applications 应用方向
For research purposes only 免责声明
本条目信息整理自公开销售页面（The Ped Shop），仅供研究与信息参考。所列产品按研究用途展示，不作为药品或保健品销售，不用于诊断、治疗、治愈或预防任何疾病。实际规格、价格与库存以供应商页面为准。
UK Launch · The Ped Shop Exclusive
A new name in research peptides, landing in the UK
SerenQ Pharmaceuticals builds research peptides into sealed, pre-filled injection pens rather than lyophilised vials. No reconstitution, no bacteriostatic water, no guesswork with a syringe barrel. Dial the units you need, read them off the window, done. Blends arrive pre-mixed at a fixed ratio, so there is nothing to combine.
SerenQ has appointed
The Ped Shop as its exclusive UK stockist
. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.
SerenQ Pharmaceuticals
Ipamorelin + CJC-1295NO DAC
Blended Peptide Injection Pen System
Ipamorelin 10mg CJC-1295 5mg
Content10mg + 5mg
Dial graduation9u = 300 / 150mcg
Per unit33.3 / 16.7mcg
Total units300u
FormatPre-filled pen
Pen tips32G 0.23 x 4mm
Expiry12/2027
AuthenticityQR + serial
Composition & Dosing Guide
The Ipamorelin + CJC-1295 pen holds 3ml of solution across 300 units, so one unit on the dial equals 0.01ml. That works out at 3.33mg/ml Ipamorelin, 1.67mg/ml CJC-1295. As a worked example, 9 units is 0.09ml, containing 0.30mg Ipamorelin, 0.15mg CJC-1295. Figures are the pen’s stated contents divided across its 300 units. For research purposes only. Not for human consumption.
Third Party Testing
Results in
This batch has been independently analysed by
Analiza Białek
in Wrocław. A sealed pen was pulled from production stock and tested by HPLC. These are the figures that came back, and the full certificate is in the gallery above.
Ipamorelin
Content per ml
3.69mg/ml
Total in pen
11.07mg / 3ml
Label claim
Result
111% of label
CJC-1295 No DAC
Content per ml
1.56mg/ml
Total in pen
4.98mg / 3ml
Label claim
Result
100% of label
Laboratory
Analiza Białek
Method
HPLC
Tested
3 September 2026
Password
S13JU98K
Check it yourself at
using password
S13JU98K
. Order number 100017373.
Serialised & QR Verified
Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.
One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.
You can verify your SerenQ authenticity and view the latest HPLC at
About the blend
This pen holds two compounds in a fixed 2:1 ratio, and the reason they are paired is that they approach the same gland from two different doors.
Ipamorelin
is a pentapeptide growth hormone secretagogue that acts on the ghrelin receptor, GHS-R1a. What set it apart from earlier secretagogues such as GHRP-6 and GHRP-2 was selectivity: published work reported growth hormone release with comparatively little disturbance to cortisol, prolactin and ACTH, and a pulsed rather than sustained release pattern.
CJC-1295 no DAC
, also written Modified GRF (1-29), is a different animal entirely. It is a shortened 29 amino acid GHRH analogue carrying four amino acid substitutions, each one there to blunt breakdown by the DPP-4 enzyme that dismantles natural GHRH within minutes. It acts on the GHRH receptor.
What “no DAC” actually means:
DAC stands for Drug Affinity Complex, a chemical group that binds the peptide to serum albumin and stretches its half-life out to days. This pen does
carry it. Without DAC the compound clears in roughly half an hour, which is why the research literature describes it as producing a short pulse rather than a sustained elevation. If you are looking for the long acting version, this is not it.
The rationale for combining them is receptor arithmetic. One acts on the GHRH receptor, the other on the ghrelin receptor, and studies examining GHRH analogues alongside secretagogues have reported a greater combined response than either produces alone. Both are short acting here, which is the point of the pairing rather than an oversight.
Where the evidence sits:
neither compound holds a medicines licence in the UK or anywhere else. Ipamorelin reached early clinical investigation before development was abandoned. CJC-1295 no DAC has not been through clinical development at all, and research on the combination specifically is limited. It is supplied here strictly as a laboratory research chemical.
The pen format
10mg Ipamorelin + 5mg CJC-1295 no DAC
per pen, pre-blended in solution
1 unit = 33.3mcg Ipamorelin and 16.7mcg CJC-1295
9 units on the dial gives 300mcg / 150mcg
300 units in total
, which works out at 33 full 9 unit draws per pen
– Dial and dose window let you set the exact amount and read it back before dispensing
– 4 screw on pen tips supplied, individually sealed,
32G 0.23 x 4mm
– Protective cap, clip and a rigid retail carton for storage and transport
– Batch number, expiry and serial printed directly on the pen barrel, not just the box
Handling and storage
– Store refrigerated at 2 to 8°C. Do not freeze
– Keep in the outer carton, away from direct light
– Short periods at room temperature during transit are expected and normal
– Use a fresh sealed tip for each dispense and dispose of tips in a sharps container
– Expiry 12/2027 on sealed, correctly stored stock
– Keep out of reach of children and animals
What is in the box
– 1 × SerenQ Ipamorelin 10mg + CJC-1295 no DAC 5mg pre-filled injection pen
– 4 × sealed pen tips, 32G 0.23 x 4mm
– Serialised, QR coded retail carton
For research purposes only
This product is sold strictly as a laboratory research chemical.
It is not a medicine, not a supplement and not a cosmetic. It is
not for human or veterinary consumption
, and it is not intended to diagnose, treat, cure or prevent any disease or condition.
Neither Ipamorelin nor CJC-1295 is licensed as a medicinal product by the MHRA, the FDA or any other regulator. Nothing on this page should be read as medical advice, a recommendation, or a suggesti